Medicare Enrolled

Dr. Murthy Chamarthy, M.D.

Radiation Oncology · Garland, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
1919 S SHILOH RD STE 400, Garland, TX 75042
4693201267
In practice since 2010 (15 years)
NPI: 1376854752 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chamarthy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chamarthy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chamarthy

Dr. Murthy Chamarthy is a radiation oncology in Garland, TX, with 15 years in practice. Based on federal Medicare data, Dr. Chamarthy performed 927 Medicare services across 230 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chamarthy received a total of $62,004 from 20 pharmaceutical and/or device companies across 159 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chamarthy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ 927 Medicare services$ $62,004 industry payments

Medicare Practice Summary

Medicare Utilization ↗
927
Medicare services
Bottom 32% in TX for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
230
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)688$0$0
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes63$9$49
Ultrasonic guidance for blood vessel access33$26$80
Fluoroscopic guidance for insertion or removal of central vein access device27$14$79
Blood draw (venipuncture)26$8$16
Basic metabolic blood panel23$8$17
Occlusion of artery with review by radiologist17$5,435$14,848
Review by radiologist of arm or leg artery image16$95$303
Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin12$110$598
Fine needle aspiration biopsy using ultrasound guidance, first growth11$56$294
Ultrasonic guidance for needle placement11$23$135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$62,004
Total received (2018-2024)
Avg $8,858/year across 7 years
Top 2% in TX for radiation oncology
20
Companies
159
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$46,597 (75.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,317 (15.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,090 (9.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,406
2023
$17,051
2022
$17,487
2021
$6,186
2020
$570
2019
$1,306
2018
$4,999

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$52,270
BOSTON SCIENTIFIC CORPORATION
$1,850
Cook Incorporated
$1,819
Cardiovascular Systems Inc.
$1,431
Stryker Corporation
$941
Abbott Laboratories
$932
Medtronic Vascular, Inc.
$749
Philips Electronics North America Corporation
$461
Inari Medical, Inc.
$335
Medtronic, Inc.
$330
Siemens Medical Solutions USA, Inc.
$312
Merit Medical Systems Inc
$285
Nevro Corp.
$68
Surmodics, Inc.
$55
Tactile Systems Technology Inc
$44
Terumo Medical Corporation
$35
Resmed Corp
$31
Cardinal Health 200 LLC
$29
Cook Medical LLC
$14
Cardinal Health 200, LLC
$13
Top 3 companies account for 90.2% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (6577) Visions 014 · (9715) Azurion 5 M20 · ABSORB · AIR 11 · ANGIODYNAMICS · AURYON LASER SYSTEM 100-120 VAC · AZUR · Artis Q ceiling · Auryon Laser System 100-120 Vac · COOK MEDICAL IAA · COOK MEDICAL PERIPHERAL INTERVENTION · CT THROMBECTOMY SYSTEM KIT · ClosureFast · Diamondback Peripheral · EMBOZENE · EXODUS · Embozene · FLEXITOUCH · FLEXOR · FLOWTRIEVER CATHETER · Flexitouch Plus · FlowMet · GENERAL VASCULAR INTERVENTION · HawkOne · JETSTREAM · MYNX CONTROLTM · OUTBACK LTD Re-Entry Catheter · Omnilink Elite vascular stent system · Peripheral Orbital Atherectomy System · Prelude Ideal Hydrophilic Sheath Introducer · S · SPINEJACK · Senza · SilverHawk · Sublime 014 Rx PTA Balloon Dilatation Catheter · Supera peripheral stent system · TheraSphere Y90 Glass Microspheres 10 GBq · TurboHawk · VENACURE 1470 PRO · VenaCure 1470 Pro · VenaSeal
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for radiation oncology in TX.

Equivalent to $6,689 per 100 Medicare services performed
Looking for a radiation oncology in Garland?
Compare radiation oncologys in the Garland area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologys nearby

Geographic Context

Radiation Oncologys within 10 mi
589
Per 100K population
22.6
County median income
$74,149
Nearest hospital
PERIMETER BEHAVIORAL HOSPITAL OF DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chamarthy is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 2%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chamarthy experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Chamarthy performed 688 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chamarthy receive payments from pharmaceutical companies?
Yes. Dr. Chamarthy received a total of $62,004 from 20 companies across 159 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chamarthy's costs compare to other radiation oncologys in Garland?
Dr. Chamarthy's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chamarthy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →